Randomized controlled trial shows improved aerosol deposition and pulmonary perfusion in post-COVID-19 patients after inspiratory muscle training, indicating its potential benefits.
Background: Pulmonary dysfunction in individuals with post-coronavirus disease-2019 (COVID-19) syndrome may impair aerosol deposition and pulmonary perfusion, compromising respiratory efficiency. Inspiratory muscle training (IMT) has been proposed as a strategy to improve respiratory mechanics and lung function. Objective: To compare aerosol deposition and pulmonary perfusion in individuals with post-COVID-19 syndrome before and after 8 weeks of IMT. Methods: This was a randomized controlled clinical trial involving 19 participants, divided into an IMT group ( n = 10) and a control group ( n = 9). The IMT group performed training with a load adjusted to 50% of maximal inspiratory pressure, while the control group used a device without resistance. Aerosol deposition and pulmonary perfusion were evaluated by gamma scintigraphy using the radioisotopes technetium-labeled diethylene-triamine-pentaacetic acid and technetium99-labeled macroaggregated human serum albumin, respectively. Total radiopharmaceutical activity in both lungs, as well as in the right and left lungs separately, was quantified pre- and post-intervention. Results: After 8 weeks, the IMT group showed a significant increase in total lung activity for both aerosol deposition ( p = 0.028) and perfusion ( p = 0.013). In the right lung, activity increased significantly for aerosol deposition ( p = 0.005) and perfusion ( p = 0.005). In the left lung, significant increases were also observed for perfusion ( p = 0.007). No significant increases were observed in the control group. In the between-group analysis, the IMT group showed higher activity in both lungs combined and separately, compared with controls, for aerosol deposition (all p < 0.05) and in the right lung for perfusion ( p = 0.010). Conclusion: IMT improved total aerosol deposition and perfusion in individuals with post-COVID-19 syndrome. These findings support the use of IMT as a rehabilitation strategy to enhance pulmonary deposition of inhaled agents and increase pulmonary perfusion in this population.
No takes yet. Share an insight, caveat, or question.
Junior et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: